BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 26693913)

  • 1. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
    Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
    Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
    Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F
    PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic utility of (18)F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Xuan W; Chicco A; Fowler A
    Radiother Oncol; 2016 Jul; 120(1):87-91. PubMed ID: 27321151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.
    Chan SC; Chang JT; Lin CY; Ng SH; Wang HM; Liao CT; Chang CJ; Lin SY; Yen TC
    Nucl Med Commun; 2011 Nov; 32(11):989-96. PubMed ID: 21862944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma.
    Chan SC; Chang KP; Fang YD; Tsang NM; Ng SH; Hsu CL; Liao CT; Yen TC
    Laryngoscope; 2017 Jan; 127(1):E22-E28. PubMed ID: 27435352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
    Zhou M; Chen Y; Huang H; Zhou X; Liu J; Huang G
    Oncotarget; 2016 Dec; 7(50):83544-83553. PubMed ID: 27835875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node standardized uptake values at pre-treatment
    Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
    Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma.
    Chen WH; Tang LQ; Zhang L; Chen QY; Guo SS; Liu LT; Fan W; Zhang X; Guo L; Zhao C; Cao KJ; Qian CN; Guo X; Xie D; Zeng MS; Mai HQ
    Oncotarget; 2015 Nov; 6(35):38296-307. PubMed ID: 26512922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
    Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
    Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of primary gross tumor volume and standardized uptake value of
    Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
    Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.
    Xie P; Yue JB; Zhao HX; Sun XD; Kong L; Fu Z; Yu JM
    J Cancer Res Clin Oncol; 2010 Jun; 136(6):883-9. PubMed ID: 19936788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
    Chen HH; Chiu NT; Su WC; Guo HR; Lee BF
    Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of
    Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E
    Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718
    [No Abstract]   [Full Text] [Related]  

  • 15. Pretreatment (18)F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma--a retrospective study.
    Yang Z; Shi Q; Zhang Y; Pan H; Yao Z; Hu S; Shi W; Zhu B; Zhang Y; Hu C
    Radiat Oncol; 2015 Jan; 10():4. PubMed ID: 25566697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding maximum standard uptake value of primary lesion and lymph nodes in 18F-fluorodeoxyglucose PET helps predict distant metastasis in patients with nasopharyngeal carcinoma.
    Shi Q; Yang Z; Zhang Y; Hu C
    PLoS One; 2014; 9(7):e103153. PubMed ID: 25068373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of post-therapy (18)F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
    Chan SC; Kuo WH; Wang HM; Chang JT; Lin CY; Ng SH; Hsu CL; Chang KP; Liao CT; Lin YJ; Yen TC
    Ann Nucl Med; 2013 Oct; 27(8):710-9. PubMed ID: 23715831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy.
    Alessi A; Lorenzoni A; Cavallo A; Padovano B; Iacovelli NA; Bossi P; Alfieri S; Serafini G; Colombo CB; Cicchetti A; Mira M; Licitra L; Fallai C; Crippa F; Orlandi E
    Radiol Med; 2019 May; 124(5):414-421. PubMed ID: 30560502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and validation of a nomogram with intratumoral heterogeneity derived from
    Gu B; Zhang J; Ma G; Song S; Shi L; Zhang Y; Yang Z
    BMC Cancer; 2020 Jan; 20(1):37. PubMed ID: 31941465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal Carcinoma.
    Hsieh TC; Hsieh CY; Yang TY; Chen TT; Lin CY; Lin CC; Hua CH; Chiu CF; Yeh SP; Sher YP
    Oncologist; 2015 May; 20(5):539-45. PubMed ID: 25876992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.